BioOra raising capital, set to begin stage two clinical trials
Wellington-based biopharma startup BioOra recently began its Series A funding roadshow and will begin its next set of clinical trials next year.
BioOra aims to revolutionise CAR-T cell therapy technology.
Local biopharma startup BioOra recently began its Series A funding roadshow, revealing a targeted capital raise of between $5 million to $20m towards its push to revolutionise personalised cancer therapy.
[image src="https://d2xgqyuql1olth.cloudfront.net/assets/Andrea-Andi-Grant.jpeg" id="98228" width="350" height="563" class="right
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Subscribe Now
Monthly Premium Online Subscription
NZ$44.95 / monthly
Subscribe Now
Smartphone Only Subscription
NZ$24.95 / monthly
Subscribe Now
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly
credit card debit
Subscribe Now
Yearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Subscribe Now
Already have an account? Login
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
